Merck to Participate in Morgan Stanley Global Healthcare Conference
ByAinvest
Tuesday, Sep 2, 2025 6:50 pm ET1min read
MRK--
The fireside chat will provide an opportunity for stakeholders to gain insights into Merck's strategic direction, research advancements, and future prospects in the healthcare sector. Merck, with its mission to use leading-edge science to save and improve lives globally, has been a key player in the pharmaceutical industry for over 130 years. The company is renowned for its contributions to the development of important medicines and vaccines [1][2].
Investors and analysts are particularly interested in Merck's forward-looking statements, which outline significant risks and uncertainties. These include general industry conditions, economic factors, regulatory changes, and technological advancements. Merck's ability to navigate these challenges and continue its research-intensive approach will be a key focus of the fireside chat [1][2].
For those unable to attend the event in person, the live audio webcast will provide a convenient way to listen to the discussion. The webcast will be available at the provided weblink.
References:
[1] https://www.theglobeandmail.com/investing/markets/stocks/MRK-N/pressreleases/34534298/merck-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference/
[2] https://www.morningstar.com/news/business-wire/20250902971149/merck-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference
Merck & Co Inc (MRK) announced that its Chairman and CEO, Robert M. Davis, and Dr. Dean Y. Li, Executive Vice President and President of Merck Research Laboratories, will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference. The event is scheduled for Monday, September 8, 2025, at 2:35 p.m. EDT. The presentation will be available via a live audio webcast for investors, analysts, media, and the public.
Merck & Co. Inc. (MRK), known as MSD outside the United States and Canada, has announced that Robert M. Davis, Chairman and CEO, and Dr. Dean Y. Li, Executive Vice President and President of Merck Research Laboratories, will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference. The event is scheduled for Monday, September 8, 2025, at 2:35 p.m. EDT. The presentation will be available via a live audio webcast for investors, analysts, media, and the public [1][2].The fireside chat will provide an opportunity for stakeholders to gain insights into Merck's strategic direction, research advancements, and future prospects in the healthcare sector. Merck, with its mission to use leading-edge science to save and improve lives globally, has been a key player in the pharmaceutical industry for over 130 years. The company is renowned for its contributions to the development of important medicines and vaccines [1][2].
Investors and analysts are particularly interested in Merck's forward-looking statements, which outline significant risks and uncertainties. These include general industry conditions, economic factors, regulatory changes, and technological advancements. Merck's ability to navigate these challenges and continue its research-intensive approach will be a key focus of the fireside chat [1][2].
For those unable to attend the event in person, the live audio webcast will provide a convenient way to listen to the discussion. The webcast will be available at the provided weblink.
References:
[1] https://www.theglobeandmail.com/investing/markets/stocks/MRK-N/pressreleases/34534298/merck-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference/
[2] https://www.morningstar.com/news/business-wire/20250902971149/merck-to-participate-in-the-morgan-stanley-23rd-annual-global-healthcare-conference

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet